Advertisement

Ventricular Tachycardias

Published:January 16, 2016DOI:https://doi.org/10.1016/j.ccep.2015.10.008

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cardiac Electrophysiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators.
        N Engl J Med. 1997; 337: 1576-1583
        • Bardy G.
        • Lee K.
        • Mark D.
        • et al.
        Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
        N Engl J Med. 2005; 352: 225-237
        • Poole J.
        • Johnson G.
        • Hellkamp A.
        • et al.
        Prognostic importance of defibrillator shocks in patients with heart failure.
        N Engl J Med. 2008; 359: 1009-1017
        • Sweeney M.
        • Sherfesee L.
        • DeGroot P.
        • et al.
        Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.
        Heart Rhythm. 2010; 7: 353-360
        • Wathen M.
        • Sweeney M.
        • DeGroot P.
        • PainFREE Investigators
        • et al.
        Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.
        Circulation. 2001; 104: 796-801
        • Sears S.
        • Conti J.
        Quality of life and psychological functioning of ICD patients.
        Heart. 2002; 87: 488-493
        • Connolly S.
        • Dorian P.
        • Roberts R.
        • Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators
        • et al.
        Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
        JAMA. 2006; 295: 165-171
        • Packer D.
        • Prutkin J.
        • Hellkamp A.
        • et al.
        Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
        Circulation. 2009; 120: 2170-2176
        • Sacher F.
        • Tedrow U.
        • Field M.
        • et al.
        Ventricular tachycardia ablation: evolution of patients and procedures over 8 years.
        Circ Arrhythm Electrophysiol. 2008; 1: 153-161
        • Palaniswamy C.
        • Kolte D.
        • Harikrishnan P.
        • et al.
        Catheter ablation of post infarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States.
        Heart Rhythm. 2014; 11: 2056-2063
        • Kramer T.
        The partition of the truncus and conus and the formation of the membraneous portion of the interventricular septum in human heart.
        Am J Anat. 1942; 71: 343-370
        • Jadonath R.
        • Schwartzman D.
        • Preminger M.
        • et al.
        Utility of the 12-lead electrocardiogram in localizing the origin of right ventricular outflow tract tachycardia.
        Am Heart J. 1995; 130: 1107-1113
        • Yamauchi Y.
        • Aonuma K.
        • Takahashi A.
        • et al.
        Electrocardiographic characteristics of repetitive monomorphic right ventricular tachycardia originating near the His-bundle.
        J Cardiovasc Electrophysiol. 2005; 16: 1041-1048
        • Yoshida N.
        • Inden Y.
        • Uchikawa T.
        • et al.
        Novel transitional zone index allows more accurate differentiation between idiopathic right ventricular outflow tract and aortic sinus cusp ventricular arrhythmias.
        Heart Rhythm. 2011; 8: 349-356
        • Hutchinson M.
        • Garcia F.
        An organized approach to the localization, mapping, and ablation of outflow tract ventricular arrhythmias.
        J Cardiovasc Electrophysiol. 2013; 24: 1189-1197
        • Yoshida N.
        • Yamada T.
        • McElderry H.
        • et al.
        A novel electrocardiographic criterion for differentiating a left from right ventricular outflow tract tachycardia origin: the V2S/V3R index.
        J Cardiovasc Electrophysiol. 2014; 25: 747-753
        • Yamada T.
        • Lau Y.
        • Litovsky S.
        • et al.
        Prevalence and clinical, electrocardiographic, and electrophysiologic characteristics of ventricular arrhythmias originating from the noncoronary sinus of Valsalva.
        Heart Rhythm. 2013; 10: 1605-1612
        • Yamada T.
        • McElderry H.
        • Doppalapudi H.
        • et al.
        Idiopathic ventricular arrhythmias originating from the left ventricular summit: anatomic concepts relevant to ablation.
        Circ Arrhythm Electrophysiol. 2010; 3: 616-623
        • Roberts-Thomson K.
        • Steven D.
        • Seiler J.
        • et al.
        Coronary artery injury due to catheter ablation in adults: presentations and outcomes.
        Circulation. 2009; 120: 1465-1473
        • Jauregui Abularach M.
        • Campos B.
        • Park K.
        • et al.
        Ablation of ventricular arrhythmias arising near the anterior epicardial veins from the left sinus of Valsalva region: ECG features, anatomic distance, and outcome.
        Heart Rhythm. 2012; 9: 865-873
        • Doppalapudi H.
        • Yamada T.
        • Ramaswamy K.
        • et al.
        Idiopathic focal epicardial ventricular tachycardia originating from the crux of the heart.
        Heart Rhythm. 2009; 6: 44-50
        • Kawamura M.
        • Gerstenfeld E.
        • Vedantham V.
        • et al.
        Idiopathic ventricular arrhythmia originating from the cardiac crux or inferior septum: an epicardial idiopathic ventricular arrhythmia.
        Circ Arrhythm Electrophysiol. 2014; 7: 1152-1158
        • Soejima K.
        • Stevenson W.
        • Sapp J.
        • et al.
        Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars.
        J Am Coll Cardiol. 2004; 43: 1834-1842
        • Cesario D.
        • Vaseghi M.
        • Boyle N.
        • et al.
        Value of high-density endocardial and epicardial mapping for catheter ablation of hemodynamically unstable ventricular tachycardia.
        Heart Rhythm. 2006; 3: 1-10
        • Nakahara S.
        • Tung R.
        • Ramirez R.
        • et al.
        Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia.
        J Am Coll Cardiol. 2010; 55: 2355-2365
        • Cano O.
        • Hutchinson M.
        • Lin D.
        • et al.
        Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy.
        J Am Coll Cardiol. 2009; 54: 799-808
        • Haqqani H.
        • Tschabrunn C.
        • Tzou W.
        • et al.
        Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications.
        Heart Rhythm. 2011; 8: 1169-1176